08 - Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL

episode

TMO EPM / Hemato H9J not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Morgan Stanley email exposes deal secrets 3 min · 23 Sep 2026 · Wall Street Breakfast

Dark Patterns: How to Escape the Subscription Trap 15 min · 23 Sep 2026 · Making Cents

The Greatest Sports Photo of All-Time | Postgame Show 12 min · 23 Sep 2026 · The Dan Le Batard Show

Steve-O's Picks + The Shipping Container's "Theatrics" | Hour 3 37 min · 23 Sep 2026 · The Dan Le Batard Show

Win Brooke's Bucks (9/23/26) 7 min · 23 Sep 2026 · Brooke and Jeffrey

Personal Finance: Grocery Price Hikes On The Way 7 min · 23 Sep 2026 · The Last Word with Matt Cooper

Report any issue

Source

Recorded24 Sep 2023

Publisheranchor.fm ↗

Handlerec:13129703

Show notes

Discussão do artigo: "Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL" de Tisi M, Blood Adv (2023) 7 (15): 3916–3924. Apresentado por: Dr. Caio Prato Discussão por: Dr. Celso Arrais, Dr. Breno Aires, Dr. Pedro Flores, Dr. Pedro Arruda e Dr. Vinícius Molla.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in